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Background: risk stratification of patients with established type 2 diabetes mellitus (DM) is under scientific 
discussion and appears to be controversial issue.
The objective: to investigate relationship between levels of growth differentiation factor-15 (GDF-15) and 
circulating number of endothelial progenitor cells (EPCs) with angiopoetic phenotypes: CD34+CD14+CD309+, and 
CD34+CD14+CD309+Tie2+ in patients with type 2 DM.
Materials and Methods. The study retrospectively involved 76 patients with type 2 DM aged 38 to 55 years 
and 30 healthy volunteers. Data collection included demographic and anthropometric information, hemodynamic 
performances and biomarkers of the disease. EPCs' populations were determined by flow cytometry.
Results. The levels of GDF-15 in peripheral blood of diabetics associated with age (r = 0.31, P = 0.044), high- 
sensitive C-reactive protein [hs-CRP] (r = 0.40, P = 0.001), smoking (r = 0.38, P = 0.001), body mass index [BMI] (r = 0.34, 
P = 0.001), LDL cholesterol (r = 0.28, P = 0.001), glycated hemoglobin [HbA1c] (r = -0.28, P = 0.001), number of CV 
risk factors (r = 0.26, P = 0.001). In univariate logistic regression analysis we found that level of GDF-15 > 618 pg/mL, 
hs-CRP > 7.12 mg/L, HbA1c > 6.4%, fasting glucose > 6.7 mmol/L, and BMI > 27.3 kg/m2 predicted deficiency of both 
angiopoetic phenotypes of EPCs. In multivariate logistic regression model GDF-15 > 618 pg/mL demonstrated the 
best odds ratio values for declining of EPCs in diabetics in comparison with other predictors including BMI, HbA1c 
and hs-CRP.
In conclusion, GDF-15 was extremely evaluated in type 2 DM population to healthy volunteers and it was an 
independent factor that contributes to mobilization and probably proliferation of endothelial precursors with high 
angiopoetic activity.
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MARKERS OF ENDOTHELIAL INJURIES IN PATIENTS WITH CORONARY HEART DISEASE AND AUTOIMMUNE THYROIDITIS
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According to WHO, coronary heart disease (CHD) has been on the top of the list of 10 leading causes of death 
in the world over the years, and its share is 12.8% [U1. CHD mortality among working age population is 28.3% [2]. At 
the same time, there is a significant increase in autoimmune thyroiditis (AIT) in society: particularly, in Ukraine the 
prevalence of AIT has increased by 68% over the past 10 years [34]. Today, endothelial dysfunction (ED) is considered 
to be the pathogenetic basis for the formation of atherosclerotic vascular lesions. ED, formed in conditions of chronic 
systemic inflammation (CSI), is the earliest stage of atherogenesis, and it plays a leading role in the progression of
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vascular changes and development of atherothrombosis[51. At the same time, CSI is the pathogenetic basis of 
AIT[3]. AIT potentiates the development of atherosclerosis (ASVD), creating an immune-inflammatory environment, 
regardless of the development of hypothyroidism, which is an indispensable consequence of AIT and results in the 
progression of cardiovascular disease[61. The above-mentioned determines the relevance of the search for indicative 
markers of endothelial injuries in conditions of the specified pathology for optimization of diagnosis, evaluation of 
the course and efficacy of therapeutic measures. Lately, significant scientific experience has been accumulated 
on the determination of ED by the level of circulating endothelial microparticles (EMP) in the bloodstream[7,81. By the 
number of EMPs with the corresponding types of molecular antigenic markers classified by the CD system (from the 
English "cluster designation"), it is possible to make a conclusion about the condition of the cells producing them[71. 
The purpose of our study was to study the condition of vascular endothelium in patients with CHD and CHD in 
combination with AIT at the level of EMP CD32+CD40+ and to compare the obtained data with the level of systemic 
inflammation.
Materials and methods. One-time, open-label clinical trial was conducted — single group study. It involved 
175 people of both sexes: 115 patients with CHD: stable angina pectoris, FC II, НF 0-І (Study Group 1), 30 patients 
with AIT in euthyroid state (Study Group 2) and 30 healthy individuals, amounted to the control group. The criteria 
for inclusion into the research were men and women's age of 40-74, the presence of CHD: angina pectoris, FC II, 
absence of destabilizing flow of CHD for at least two months, as well as the presence of concomitant AIT in the 
stage of euthyroidism, and the patient's informed consent to participate in the research. The exclusion criteria 
were the presence of Stage 2 hypertension, Stage 1 chronic heart failure (CHF), complications of cardiac rhythm 
and conduction, rheumatic diseases, anemia, diabetes mellitus, chronic liver and kidney disease with functional 
impairment, cancer. To all participants of the study a determination of the amount of EMPs in peripheral blood with 
expression of CD32 and CD40 antigens was made by flow cytometry using monoclonal antibodies[91. CD32 (FCyRIIB) 
is an immunoglobulin superfamily receptor, CD40 belongs to the tumor necrosis factor alpha (TNFa) superfamily, 
both antigens play an important role in inflammatory signaling[ia 111. TNFa was studied as a CSI marker by the immune- 
enzymatic method[121.
Results. In patients from Study Group 1 (CHD) and Study Group 2 (CHD in combination with AIT), the content of 
EMP CD32+CD40+ in peripheral blood was significantly higher than in healthy individuals, who had the value of this 
index of 1.3 (1.05-2.11) x 107/L. At the same time, the content of EMP CD32+CD40+ in patients from Study Group 2 
was significantly higher than in Study Group 1, and was 2.62 (1.50-6.10) x 107/L versus 1.8 (1.12-4.96) x 107/L (p=0.036). 
It indicates a high level of inflammatory activation of the endothelium in conditions of chronic autoimmune 
inflammation. When comparing the results of study of EMP CD32+CD40+ in all the groups, it was found that a value 
greater than 2.5 x 107/L indicates endothelial injury. The sensitivity (Se) and specificity (Sp) of the endothelial injury 
detection method were calculated using EMP CD32+CD40+ in AIT in combination with CHD: Se was 82%, Sr - 83%. In 
patients of both groups, the level of TNFa in the blood was elevated, while with the combination of CHD and AIT the 
level of TNFa was significantly higher than in patients with CHD alone (10.54+2.42 pg/mL versus 8.53+3.24 pg/mL). A 
close correlation between values of EMP CD32+CD40+ and TNFa in patients with CHD in combination with AIT (r=0.81, 
p<0.05) was found out. According to the data, the value of EMP > 2.5 x 107/L corresponds to the value of TNFa > 7.9 
pg/mL. Se and Sr showed an increase in TNFa > 7.9 pg/mL as a marker, confirming the presence of endothelial injury 
in CHD in combination with AIT: Se was 100%, Sr - 82%.
The amount of EMP CD32+CD40+ in the blood is a reliable marker of inflammatory activation and destruction of 
vascular endothelium in CHD and CHD in combination with AIT. With a combination of CHD and AIT, increasing the 
TNFa content is a probable marker of inflammatory endothelial injury.
The use of the indicator of EMP CD32+CD40+ in the blood, as well as the study of EMP with other antigenic 
molecular markers, will expand the understanding the mechanisms of development and course of diseases with 
vascular injuries in the pathogenesis, and develop effective diagnostic approaches.
Determining the amount of EMP CD32+CD40+ in the blood is a highly sensitive method for verifying inflammatory 
endothelial injury, with CHD and CHD in combination with AIT in particular, and may be recommended for 
widespread use with the aim of early diagnosis of vascular injury, its progression, and to evaluate the efficacy of 
therapeutic measures.
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Drugs of herbal origin have proven to be effective in many anxiety disorders. EGb-761, EGB-761, a standardized 
extract of the Ginkgo biloba [Leaf] containing 24% of flavone glycosides (quercetin, kaempferol and iso rhamnetin) 
and 6% of terpenes (gingkolides and bilobalides) is an effective anxiolytic, neuroprotective and nootropic agent, 
despite its influential roles in various ailments of central nervous system, the data available in the treatment of 
obsessive compulsive disorder (OCD), a debilitating anxiety disorder and fourth most common forms of mental illness 
with server memory impairment, is scarce.
Materials and Methods. In this study, we evaluated the effect of Ginkgo biloba extract, EGb-761 50, 100 and 200 
mg/kg on OCD using quinpirole (0.5 mg/kg) induced compulsive checking in rats and marble burying behaviour in 
mice, Rats were trained using Morris water maze apparatus before the induction of OCD and was used to evaluate 
the effect on spatial memory, the compulsions induced with quinpirole were assessed using an open field, on the 
last day of the treatment various behavioural parameters at each object were analysed such as: Frequency and 
duration of stops, Number of visits to other objects on successive return to each object and ritualistic behaviour for 
a period of 55 min.
Results. The effect on memory was evaluated based on the retention of the learned task i.e. time taken for the 
identification of the platform in Morris water maze apparatus and the underlying mechanisms are predicted based 
on the studies of brain monoamines such as dopamine and serotonin. EGb-761 at 100 and 200 mg/kg had shown 
significant improvement against quinpirole induced compulsions, a protective effect on memory task was observed 
in EGb treated rats. This could be attributed to the increase in serotonin and decrease in the dopamine levels. 
The interaction between the dopaminergic and serotonergic systems in the mid-brain regions i.e. substantia nigra 
and ventral tegmentum, with dopaminergic neurons being targets for serotonin cells explains the involvement of 
serotonin and dopamine in OCD. Activation of 5HT1A (autoreceptor) inhibits dopamine release in the dorsal striatum 
and enhances dopamine release in nucleus accumbens. This explains the possible mechanism of the effect of SSRI's 
in the treatment of DA agonist induced OCD, as quinpirole is agonist to D2 and D3 receptors in the striatum which in 
turn increases the dopamine levels. The increase in the serotonin concentration with EGb-761, its role on 5HT1A-auto- 
receptors, which inhibit dopamine release and studies, on sertraline that it decreases the extracellular dopamine 
in the striatum, further supports the observation and the resulting decrease in dopamine levels observed in the 
present study, contributes to the protective effect of EGb and paroxetine in OCD. The protective effect of EGb-761 
in the treatment of OCD is evident with both the performance on the open field and marble burying behaviour. The 
number of marbles buried by the end of 10 min was calculated after 1, 14, 28 days of treatment for all the groups.
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